Mouse NOV/CCN3 Biotinylated Antibody

Catalog #: BAM19761 Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
BAM19761

All NOV/CCN3 Antibodies

Product Details

Supplemental Products

Reviews

Summary Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Mouse NOV/CCN3 Biotinylated Antibody Summary

Species Reactivity

Mouse

Specificity

Detects mouse NOV/CCN3 in ELISAs.

Source

Monoclonal Rat IgG_2A Clone # 231210

Purification

Protein A or G purified from hybridoma culture supernatant

Immunogen

Mouse myeloma cell line NS0-derived recombinant mouse NOV/CCN3
Ser26-Ile354
Accession # Q64299

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.

Label

Biotin

Applications

Recommended Concentration

Sample

Mouse NOV/CCN3 Sandwich Immunoassay

Recommended Concentration

Reagent

ELISA Detection (Matched Antibody Pair)

0.5-2.0 µg/mL

Use in combination with:

Capture Reagent: Mouse NOV/CCN3 Antibody (Catalog # MAB19762)

Standard: Recombinant Mouse NOV/CCN3 Protein, CF (Catalog # 1976-NV)

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: NOV/CCN3

NOV, also called CCN3, is one of six CCN (CYR61/CTGF/NOV) secreted proteins which share a common multimodular organization (1‑4). NOV/CCN3 contains an N‑terminal IGFBP domain that appears to be non-functional and a vWF type C and thrombospondin type I domain which mediate oligomerization and matrix interactions, respectively (1, 2). The C-terminal cysteine knot domain interacts with several partners, including the matrix protein fibulin 1C (5), Notch-1 (6), and CCN2, which it may heterodimerize (2). NOV/CCN3 also interacts with the gap junction protein Connexin43 and mediates suppression of proliferation (7). It also binds the calcium binding protein S100A4 and promotes calcium channel activation (8). The 354 amino acid (aa), 44 kDa human NOV/CCN3 shares 80% aa identity with mouse, rat and canine NOV/CCN3, and 78% aa identity with bovine NOV/CCN3. NOV/CCN3 also shows 38‑50% aa identity with other family members including WISP proteins, except for WISP-2/CCN5 which lacks the cysteine knot (1). NOV/CCN3 is widely expressed developmentally, especially in muscle, endothelium, nervous system, adrenal cortex and chondrocytes (1‑4). In transformed cells, a 32 kDa N‑terminally truncated form lacks the signal sequence is localized to the nucleus. Truncation allows a C-terminal nuclear localization sequence to be active (9). Nuclear NOV/CCN3 acts as a transcriptional repressor but promotes proliferation, presumably by interfering with growth control (9). Full length NOV/CCN3 is a secreted matricellular protein which inhibits cell growth. Interaction of NOV/CCN3 with integrins alpha _v beta ₃ and alpha ₅ beta ₁ mediates endothelial cell adhesion, induces chemotaxis and promotes angiogenesis (10, 11). Over-expression of NOV/CCN3 downregulates myogenic genes such as MyoD (12).

References

Perbal, B. (2004) Lancet 363:62.
Perbal, B. (2006) Cell Commun. Signal. 4:3.
Martinerie, C. et al. (1994) Oncogene 9:2729.
Snaith, M. R. et al. (1996) Genomics 38:425.
Perbal, B. et al. (1999) Proc. Natl. Acad. Sci. USA 96:869.
Sakamoto, K. et al. (2002) J. Biol. Chem. 277:29399.
Fu, C. T. et al. (2004) J. Biol. Chem. 279:36943.
Li, C. L. et al. (2002) Mol. Pathol. 55:250.
Planque, N. et al. (2006) J. Cell. Biochem. Apr. 5 [e-pub ahead of print].
Lin, C. G. et al. (2003) J. Biol. Chem. 278:24200.
Lin, C. G. et al. (2003) J. Biol. Chem. 280:8229.
Calhabeu, F. et al. (2006) Exp. Cell. Res. 312:1876.

Long Name

Nephroblastoma Overexpressed Gene

Entrez Gene IDs

4856 (Human); 18133 (Mouse)

Alternate Names

CCN family member 3; CCN3; CCN3IGF-binding protein 9; IBP-9; IGFBP-9; IGFBP9novH; Insulin-like growth factor-binding protein 9; nephroblastoma overexpressed gene; Nephroblastoma-overexpressed gene protein homolog; NOV; NOVH; protein NOV homolog